# Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions

> **NCT04132843** · NA · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Brain Neoplasm
- Lymphoma
- Metastatic Malignant Neoplasm in the Brain
- Recurrent Malignant Brain Neoplasm

## Interventions

- **DRUG:** Gadobenate Dimeglumine
- **DRUG:** Gadobutrol
- **PROCEDURE:** Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT04132843
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-10
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04132843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04132843, "Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04132843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*